Tuesday, 7 April 2026

DHURANDHARTHEREVENGE INCHES AWAY FROM ₹1,000 CRORE IN INDIA

 *#DHURANDHARTHEREVENGE INCHES AWAY FROM ₹1,000 CRORE IN INDIA!*



*CROSSES ₹950 CRORES (INDIA NETT) BY END OF WEEK 2*


*CONTINUES RECORD-SMASHING GLOBAL RUN, GROSSING ₹1,500 CRORES WORLDWIDE*


Jio Studios & B62 Studios’ Aditya Dhar directorial *#DhurandharTheRevenge* continues its historic box-office domination, now just inches away from the coveted ₹1,000 Crore nett milestone in India, earning a phenomenal *₹961 Crores nett by the end of Week 2,* a feat never achieved at this pace before.


Globally, the film continues to soar with a staggering *₹1,501 Crores worldwide gross*, underlining its extraordinary international dominance as well.


Within just two weeks, it also emerged as the *biggest Indian grosser*, redefining global benchmarks for Indian cinema.


After a thunderous opening and a record second weekend, the film has held exceptionally strong through the weekdays of Week 2 (Monday to Thursday), delivering remarkable collections and maintaining its dominance across India and key international markets.


*BREAK-UP (INDIA)*


*WEEK 1 TOTAL (8 DAYS) – ₹690.00 Cr (nett)*

*Second Weekend Total – ₹177.00 Cr*


*WEEK 2 WEEKDAYS*


Day 12 – Monday – ₹26 Cr

Day 13 – Tuesday – ₹28 Cr

Day 14 – Wednesday – ₹21 Cr

Day 15 – Thursday – ₹19 Cr


*Week 2 Total – ₹271 Cr*


*India NBOC – ₹961.00 Cr*


*India GBOC – ₹1,134 Cr*


*OVERSEAS*

*Week 1 + Week 2 – ₹367 Cr*


*GROSS BOX OFFICE WORLDWIDE*


*₹1,501 CRORES*

 

*Dhurandhar The Revenge — Record Run*

- Biggest Hindi opener of all time

- Highest paid previews ever

- Biggest opening weekend worldwide

- Highest first week collections

- Highest second week collections

- Fastest film to ₹1000 Crores globally

- Fastest 100 cr, 200 cr, 300 cr, 400 cr, 500 cr, 600 cr, 700 cr, 800 cr & 900 cr

- Biggest Indian film ever in overseas markets (within Week 1)

- Highest grossing Indian film in North America

- Surpassed Dhurandhar Part 1 overseas lifetime in just 10 days

No comments:

Post a Comment